Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Irina B. Bondareva
Observed names:
I. B. Bondareva,
I. Bondareva,
I.B. Bondareva,
Irina Bondareva,
И. Б. Бондарева
Institutions:
Peoples' Friendship University of Russia,
First Pavlov State Medical University of St. Petersburg
Observed institutions:
Peoples' Friendship University of Russia,
University of Washington,
First Pavlov State Medical University of St. Petersburg,
Research Centre for Medical Genetics,
Federal Research and Clinical Center of Physical-Chemical Medicine named after Y.M. Lopukhin
ORCID:
0000-0002-8436-8931
Observed ORCIDs:
0000-0002-8436-8931,
0009-0006-4148-9481
OpenAlex ID:
A5075568038
Health-related quality of life in Russian adults with epilepsy: The effect of socio-demographic and clinical factors
2012
·
Elina Melikyan
, Alla Guekht
, et al.
·
Epilepsy & Behavior
·
58
Placebo responses in randomized trials of antiepileptic drugs
2009
·
A.B. Guekht
, A.D. Korczyn
, et al.
·
Epilepsy & Behavior
·
43
Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage
2006
·
I. B. Bondareva
, R. W. Jelliffe
, et al.
·
Journal of Clinical Pharmacy and Therapeutics
·
32
PDF
Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage
2004
·
I. B. Bondareva
, R. W. Jelliffe
, et al.
·
Journal of Clinical Pharmacy and Therapeutics
·
24
Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy
2010
·
I. B. Bondareva
, R. W. Jelliffe
, et al.
·
Journal of Clinical Pharmacy and Therapeutics
·
20
PDF
Population pharmacokinetic modelling of carbamazepine by using the iterative Bayesian (IT2B) and the nonparametric EM (NPEM) algorithms: implications for dosage
2001
·
I. B. Bondareva
, A. V. Sokolov
, et al.
·
Journal of Clinical Pharmacy and Therapeutics
·
15
PDF
Population PK/PD modelling of meropenem in preterm newborns based on therapeutic drug monitoring data
2023
·
Sergey Zyryanov
, Irina Bondareva
, et al.
·
Frontiers in Pharmacology
·
6
PDF
Pharmacokinetics of Anti-bacterial Preparations in Cystic Fibrosis in Children
2019
·
Yu.A. Kondakova
, A.Yu. Voronkova
, et al.
·
Siberian medical review
·
5
PDF
Individualizing Antiepileptic Therapy for Patients
2016
·
I. Bondareva
·
Elsevier eBooks
·
5
Results of a pilot clinical trial of the safety and efficacy of an original glycoprotein IIb/IIIa receptor inhibitor in acute coronary syndrome
2023
·
S. V. Lukyanov
, Yu. F. Glukhov
, et al.
·
CARDIOVASCULAR THERAPY AND PREVENTION
·
4
PDF
Effect of medication adherence on the risk of cardiovascular events in outpatients with stable coronary artery disease: results of two-year monitoring
2023
·
S. B. Fitilev
, A. V. Vozzhaev
, et al.
·
Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
·
4
PDF
Optimizing Individualized Dosage Regimens of Potentially Toxic Drugs
2004
·
Roger W. Jelliffe
, Alan Schumitzky
, et al.
·
Springer eBooks
·
4
Some features of statistical analysis of spontaneous adverse drug reporting data
2024
·
I. B. Bondareva
, S. K. Zyryanov
, et al.
·
Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
·
3
Safety, pharmacokinetics and pharmacodynamics of an original glycoprotein IIb/IIIa inhibitor in healthy volunteers: results of the clinical trial
2022
·
S. B. Fitilev
, Yu. F. Glukhov
, et al.
·
CARDIOVASCULAR THERAPY AND PREVENTION
·
3
PDF
Value of comparative studies of “real clinical practice” in modern cardiology. Position paper based on the expert council discussion dated 12/18/2020
2021
·
Yu. N. Belenkov
, G. P. Arutunov
, et al.
·
Kardiologiia
·
3
PDF
Analysis of treatment satisfaction and adherence among patients with type 2 diabetes
2020
·
M. F. Kalashnikova
, I. B. Bondareva
, et al.
·
Almanac of Clinical Medicine
·
3
PDF
Effectiveness and safety of empegfilgrastim (Extimia®, BIOCAD) in patients with lymphoproliferative diseases receiving cytotoxic therapy: results of LEGERITY, a multicenter retrospective-and-prospective observational post-marketing study
2024
·
Ekaterina S. Nesterova
, Aleksandra F. Saydullaeva
, et al.
·
Journal of Modern Oncology
·
2
PDF
Abstract P3-07-23: Defendor Special: Primary empegfilgrastim prophylaxis (prolonged G-CSF) for optimal treatment outcomes in high risk early breast cancer cohort. The interim analysis
2023
·
Irina Sorokina
, Inna Ganshina
, et al.
·
Cancer Research
·
2
Адаптивный дизайн в клинических исследованиях: преимущества и риски
2017
·
И. Б. Бондарева
·
Качественная клиническая практика
·
2
Adaptation of the 12-item medication adherence scale ( the Questionnaire for assessment of adherence to Medication) on a Russian-speaking sample of patients with type 1 and type 2 diabetes mellitus
2024
·
V. E. Epishin
, M. F. Kalashnikova
, et al.
·
Problems of Endocrinology
·
1
PDF
Pharmacokinetics of a novel anti-platelet drug from the glycoprotein IIb/IIIa receptor inhibitors group
2022
·
S. B. Fitilev
, Yu. F. Glukhov
, et al.
·
Pharmacokinetics and Pharmacodynamics
·
1
PDF
Pharmacokinetic analysis of meropenem therapeutic drug monitoring data (TDM) in critically ill adult patients
2022
·
I. B. Bondareva
, S. K. Zyryanov
, et al.
·
Antibiot Khimioter = Antibiotics and Chemotherapy
·
1
PDF
Overview of anticonvulsant therapy in full-term and premature neonates
2020
·
M. A. Ivzhits
, S. K. Zyryanov
, et al.
·
Russian Journal of Child Neurology
·
1
PDF
Age Peculiarities of Pharmacotherapy With Amoxicillin Preparations in Children With Cystic Fibrosis
2019
·
E.I. Kondratieva
, Yu.A. Kondakova
, et al.
·
PEDIATRIA Journal named after G N SPERANSKY
·
1
Comparative assessment of the efficacy of primary and secondary corneal endothelial dystrophy treatment by isolated descemetorhexis and accelerated collagen crosslinking method
2018
·
Sergey Yu. Astakhov
, Inna A. Riks
, et al.
·
Ophthalmology Reports
·
1
PDF
Show more works
View as search
Works count:
43
Citation count:
244
H-index:
6
I10-index:
6
Year
Topic
Type